IL-1β has a particular association with AD because in both mouse models and human, it has been shown responsible for cognitive deficits, as measured by MMSE, (Tarkowski et al., 2003) and tau pathology in triple transgenic AD mice (Kitazawa et al., 2011). This evidence concerns the gene MAPT and Alzheimer disease.